/= 80 mL benign prostatic enlargement: a large, multicentre cohort study"." /> /= 80 mL benign prostatic enlargement: a large, multicentre cohort study". BJU Int. 2022;130:696. " />

Read + Share

Baboudjian M, Fourmarier M. Re: "Rezum therapy for >/= 80 mL benign prostatic enlargement: a large, multicentre cohort study". BJU Int 2022;130:696.
PMID: 36263584

• /= 80 mL benign prostatic enlargement: a large, multicentre cohort study".&body=Re: "Rezum therapy for >/= 80 mL benign prostatic enlargement: a large, multicentre cohort study". Baboudjian M, Fourmarier M. BJU Int 2022;130:696. https://m.amedeo.com/36263584 " ALT="Email" TITLE="Email">Email

• /= 80 mL benign prostatic enlargement: a large, multicentre cohort study".&summary=Baboudjian M, Fourmarier M. Re: "Rezum therapy for >/= 80 mL benign prostatic enlargement: a large, multicentre cohort study". BJU Int 2022;130:696.&source=https://m.amedeo.com" target="linkedin">LinkedIn

• Facebook

• /= 80 mL benign prostatic enlargement: a large, multicentre cohort study".&url=http%3A%2F%2Fm.amedeo.com/36263584" target="twitter">Twitter

---

Privacy Policy